Adverse event compliance
This article was originally published in The Tan Sheet
Executive Summary
Firms have to comply with all aspects of the adverse event reporting law, the Dietary Supplement and Nonprescription Drug Consumer Protection Act, by Dec. 22, 2007. Based on language from the Senate HELP committee report and on comments by a member of Sen. Orrin Hatch's, R-Utah, staff who worked on the bill, "The Tan Sheet" previously reported firms had an additional year for labeling provisions. According to Senate Report 109-324 that accompanied the bill, "The general effective date of these amendments [to the FDCA] will be 1 year after enactment, although any labeling changes that may be required will take effect after another year." However, the law itself states that products are misbranded "unless the label ... includes a domestic address or domestic phone number through which the responsible person ... may receive a report of a serious adverse event." This misbranding "shall apply to any dietary supplement labeled on or after the date that is 1 year after the date of enactment of this Act." FDA also asserts that "any supplement labeled on or after Dec. 22, 2007 that does not have the required information is misbranded." It should be noted that the agency's draft guidance on AERs did not specifically recommend that labeling include street address information in addition to the city, state and zip code information already required by food labeling law...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.